medical

Editor’s note: This story has been corrected to reflect that Curaleaf is headquartered in New York City. Curaleaf CEO Matt Darin told Benzinga at the Cannabis Capital Conference in Miami that the company has recently increased its presence in New York. The New York City-based...

Editor’s note: This story has been updated to correct the spelling of Anna-Sophia Kouparanis’ name. Since the legalization of medical cannabis in Germany in 2017, the industry has faced notable challenges, chiefly the scarcity of physicians ready to prescribe these treatments. Anna-...

Georgia's MMJ Bid Process Gets Another Review, Losing Parties Cry Corruption The Georgia Court of Appeals is poised to weigh in on a lawsuit filed by five Georgia-based medical marijuana companies which have challenged the state's medical marijuana licensing process, claiming it was corrupt...

Curaleaf Opens New Store In Florida & Arizona On Heels Of Tryke Deal Last week, Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) launched cannabis sales in two cannabis shops, one in Florida and the other in Arizona. Located at 9268 SE Maricamp Rd in Ocala, the new 3,216-square-foot store is...

Jushi Expands In Virginia With New MMJ Shop In Fairfax Cannabis operator Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) is planning to kick off medical cannabis sales at its fourth medical cannabis dispensary in Virginia and 35th retail location nationwide on Wednesday, Aug. 31. Located at 10521...

A consortium of private equity firms bought a majority stake in medical supplier Medline Industries Inc, which according to sources familiar with the matter, is a deal valued at more than $30 billion. What Happened: Private equity firms comprising of Blackstone Group Inc (NYSE:...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after the Food and Drug Administration (FDA) rejected its regulatory application seeking label expansion for its dementia drug. The Acadia Analysts: Goldman Sachs analyst Salveen Richter downgraded Acadia shares...

ICAD Inc (NASDAQ: ICAD) is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated coverage of iCAD with a Buy rating and a price target of $25. The iCAD Thesis: The company...

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of Decipher Biosciences, Inc.  What Happened: With the cancer...

A version of this post was originally published on The Fresh Toast. You’ve probably read this a thousand times this year already: cannabis is going mainstream by the minute. In the past couple of months, we’ve seen Jim Cramer weigh in on pot stocks on "Mad Money," witnessed...

The Republic of Vanuatu, a 277,000-person South Pacific nation, has legalized medical cannabis. According to a series of official documents procured by Benzinga, the country will now allow the cultivation, production and use of medical marijuana. The plant was previously allowed to...

Greg Rovner isn't your average CEO. He has no college education and opened his first business after high school. He sold that business in 2017, after 20 years, to focus on a new venture he decided to pursue alongside a few friends who’ve been by his side since the fifth grade. Meet Heally...

A rising tide lifts all ships. And nowhere is this more relevant than in the cannabis space. Just look at the deal Canopy Growth Corp (NYSE: CGC) landed with Constellation Brands (NYSE: STZ) just two months ago. That deal, which had Constellation Brands pony up $4 billion for a piece...

Money is flowing into the cannabis industry at an unprecedented pace. And it’s not just the Canopy Growth Corp (NYSE: CGC) and Cronos Group Inc (NASDAQ: CRON)’s of the world on the receiving end: public and private companies across the spectrum are drawing ...